Clinical Evaluation of the Diagnostic Role of MicroRNA-155 in Breast Cancer

Table 5

Two-way ANOVA results for age, age of menarche, history of abortion, contraceptive drug usage, and BMI in the patient and control groups.

Groups	Sample size		-fold	^ǂ	^¥ (tumor vs. normal)
	Control group	Cancer group
Age
<48 y	18	18		Age: 0.899^ǂ	0.925
≥48 y	18	18		BC: <0.0001^ǂ	0.873
Menarche age
<13	9	13		Menarche: 0.741^ǂ	0.0017
≥13	27	23		BC: <0.0001^ǂ	<0.001
Abortion
Yes	17	15		Abortion: 0.045^ǂ	0.001
No	19	21		BC: <0.0001^ǂ	<0.001
Contraceptive drugs
Yes	14	16		Contraceptive drugs: 0.557^ǂ	0.004
No	22	20		BC: <0.0001^ǂ	<0.001
Number of pregnancies
≤4	20	22		Pregnancy number: 0.266^ǂ	<0.001
>5	16	14		BC: <0.0001^ǂ	<0.001
BMI
	14	9		BMI: 0.437^ǂ	0.002
	16	16		BC: <0.0001^ǂ	0.0025
	6	11			0.0034

^ǂThe two-way analysis of variance (ANOVA) was used for the comparison. ^¥Tukey multiple comparison.